Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study. - Georgakopoulou, Vasiliki Epameinondas; Gkoufa, Aikaterini; Makrodimitri, Sotiria; Basoulis, Dimitrios; Tsakanikas, Aristeidis; Karamanakos, Georgios; Mastrogianni, Elpida; Voutsinas, Pantazis M.; Spandidos, Demetrios A.; Papageorgiou, Chrysovalantis V.; Gamaletsou, Maria N.; Sipsas, Nikolaos V. (Experimental & Therapeutic Medicine, 2023)